Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses
Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
AGN-190584 has gone through many clinical trials showing its safety and effectiveness in
individuals from 40-55 years of age. There has been no published data on the use of this
product in individuals corrected with contact lenses for distance vision. There are many
other applications AGN-190584 could be used for and further studies will show the
effectiveness for each.